CYP11β1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia

Journal of Paediatrics and Child Health

Volumn 32, Issue 5, 1996, Pages 433-438

  Burren, C P ^a   Montalto, J ^a   Yong, A B W ^a   Batch, J A ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Congenital adrenal hyperplasia; CYP11 1 deficiency

Indexed keywords

OXYGENASE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; ENZYME DEFICIENCY; FEMALE; HUMAN; HYPERANDROGENISM; HYPERTENSION; MALE; PRIORITY JOURNAL;

EID: 0029963755     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb00945.x     Document Type: Article

References (29)

1. Shepard TH, Clausen SW. Case of adrenogenital syndrome with hypertension treated with cortisone. Pediatrics 1951; 8: 805-13.
2. Eberlein WR, Bongiovanni AM. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J. Biol. Chem. 1956; 223: 85-94.
3. Nelson DR, Kamataki T, Waxman DJ et al. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell. Biol. 1993; 12: 1-51.
4. White PC, Speiser PW. Steroid 11 beta-hydoxylase deficiency and related disorders. Endocrinol. Melab. Clin. N. Am. 1994; 23: 325-39.
5. Azziz R, Boots LR, Parker CR Jr, Bradley E Jr, Zacur HA. 11 beta-hydroxylase deficiency in hyperandrogenism. Fertil. Steril. 1991; 55: 733-41.
6. Rösler A, Leiberman E, Cohen T. High frequency of congenital adrenal hyperplasia (classic 11-beta-hydroxylase deficiency) among Jews from Morocco. Am. J. Med. Genet. 1992; 42: 827-34.
7. White PC. Disorders of aldosterone biosynthesis and action. N. Engl. J. Med. 1994; 331: 250-8.
8. Curnow KM, Slutsker L, Vitek J et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc. Natl Acad. Sci. USA 1993; 90: 4552-6.
9. Nakagawa Y, Yamada M, Ogawa H, Igarashi Y. Missense mutation in CYP11B1 (CGA {Arg-384} - >GGA [Gly]) causes steroid 11 beta-hydroxylase deficiency. Europ. J. Endocrinol. 1995; 132: 286-9.
10. Skinner CA, Rumsby G. Steroid 11 beta-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene. Hum. Mol. Genet. 1994; 3: 377-8.
11. White PC, Curnow KM, Pascoe L. Disorders of steroid 11-beta hydroxylase isoenzymes. Endocrine Rev. 1994; 15: 421-38.
12. Holcombe JH, Keenan BS, Nichols BL, Kirkland RT, Clayton GW. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia. Pediatrics 1980; 65: 777-81.
13. Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11-beta hydroxylase deficiency. J. Clin. Endocrinol. Metab. 1983; 56: 222-9.
14. Tanner JM. Growth at adolescence, with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity, 2nd edn. Blackwell, Oxford, 1962.
15. National Heart Lung Institute. Report of the Second Task Force on Blood Pressure Control in Children 1987. Pediatrics 1987; 79: 1-25.
16. Yong ABW, Pitt JJ, Montalto J, Davies HE, Warne GL, Connelly JF. Diagnosis of 21-hydroxylase deficiency in newborn infants by GC-MS of urinary steroids. Aust. Paediatr. J. 1988; 24: 280-5.
17. Yong ABW, Montalto J, Pitt JJ, Oakes S, Preston T, Buchanan C. Corticosterone methyl oxidase type II (COM II) deficiency: Biochemical approach to diagnosis. Clin. Biochem. 1994; 27: 491-4.
18. Montalto J, Whorwood CB, Funder J et al. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia. Clin. Endocrinol. 1990; 32: 1-12.
19. Lim YJ, Batch JA, Warne GL Adrenal 21-hydroxylase deficiency in childhood: 25 years' experience. J. Paediatr. Child Health 1995; 31: 222-7.
20. Cathelineau G, Brerault JL, Fiet J, Julien R, Dreux C, Canivet J. Adrenocortical 11 beta-hydroxylation defect in adult women with postmenarchial onset of symptoms. J. Clin. Endocrinol. Metab. 1980; 51: 287-91.
21. Glenthoj A, Nielsen MD, Starup J. Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency: Final diagnosis in adult age in three patients. Acta Endocrinol. 1980; 93: 94-9.
22. Newmark S, Dluhy RG, Williams GH, Pochi P, Rose LI. Partial 11- and 21-hydroxylase deficiencies in hirsute women. Am. J. Obstet. Gynecol. 1977; 127: 595-8.
23. Hochberg Z, Benderly A, Zadik Z. Salt loss in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Arch. Dis. Child. 1984; 59: 1092-3.
24. Godard C, Geering J, Geering K, Vallotton MB. Plasma renin activity related to sodium balance, renal function and urinary vasopressin in the newborn infant. Pediatr. Res. 1979; 13: 742-5.
25. Bauer JH. Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications. Drugs Aging 1993; 3: 238-45.
26. Ulick S. Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone pathway. J. Clin. Endocrinol. Metab. 1976; 43: 92-6.
27. de Simone G, Tommaselli AP, Rossi R et al. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension. Hypertension 1985; 7: 204-10.
28. White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rosler A. A mutation in CYP11B1 (Arg-448 - His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J. Clin. Invest, 1991; 87: 1664-7.
29. Rösler A, Wesler N, Leiberman E et al. 11 beta-hydroxylase deficiency congenital adrenal hyperplasia: Update of prenatal diagnosis. J. Clin. Endocrinol. Metab. 1988; 66: 830-8.